Clinical trial
Phase 2 Study in Evaluation of the Efficacy and Safety of Haemate HS in This Clinical Setting (Patients With Severe Bleeding Undergoing Valve Replacement Due to Aortic Stenosis)
NCT00618293 is registered in ClinicalTrials.gov with Heinrich-Heine University, Duesseldorf as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2 Study in Evaluation of the Efficacy and Safety of Haemate HS in This Clinical Setting (Patients With Severe Bleeding Undergoing Valve Replacement Due to Aortic Stenosis)
- Lead sponsor
- Heinrich-Heine University, Duesseldorf
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- January 31, 2008
- Completion date
- July 31, 2011
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
Lead sponsor's other trials
Heinrich-Heine University, Duesseldorf, most recent start first.
+174 more trials See the organization page
Similar trials
Same condition (Blood Loss, Surgical) and phase, most recent start first.
+5 more trials See the condition page